FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

BA Conley

Research Profile

Chemicals & Drugs

Disorders

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Sreenivasa R Chandana; Howard T Chang; Anas Al-Janadi; Rupesh Kotecha; BA Conley
Rare case of hairy cell leukemia with brain parenchymal involvement: a diagnostic dilemma.
P Michael Williams; J Milburn Jessup; Tracy G Lively; BA Conley
Bridging the gap: moving predictive and prognostic assays from research to clinical use.
Kevin J Patel; Sreenivasa R Chandana; David A Wiese; Brian Olsen; BA Conley
Unusual presentation of large-cell poorly differentiated neuroendocrine carcinoma of the epiglottis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of BA Conley (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sreenivasa R Chandana; Howard T Chang; Anas Al-Janadi; Rupesh Kotecha; BA Conley
Rare case of hairy cell leukemia with brain parenchymal involvement: a diagnostic dilemma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(11):e186-8.
2012: P Michael Williams; J Milburn Jessup; Tracy G Lively; BA Conley
Bridging the gap: moving predictive and prognostic assays from research to clinical use.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(6):1531-9.
2010: Kevin J Patel; Sreenivasa R Chandana; David A Wiese; Brian Olsen; BA Conley
Unusual presentation of large-cell poorly differentiated neuroendocrine carcinoma of the epiglottis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(27):e461-3.
2010: Shivaani Kummar; Martin E Gutierrez; Erin R Gardner; Xiaohong Chen; William D Figg; Maria Zajac-Kaye; Min Chen; Seth M Steinberg; Christine A Muir; Mary Ann Yancey; Yvonne R Horneffer; Lamin Juwara; Giovanni Melillo; S Percy Ivy; Maria Merino; Len Neckers; Patricia S Steeg; BA Conley; Giuseppe Giaccone; James Doroshow; Anthony J Murgo
Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies.
European journal of cancer (Oxford, England : 1990) 2010;46(2):340-7.
2010: Shivaani Kummar; Martin E Gutierrez; Erin R Gardner; William D Figg; Giovanni Melillo; Janet Dancey; Edward A Sausville; BA Conley; Anthony J Murgo; James Doroshow
A phase I trial of UCN-01 and prednisone in patients with refractory solid tumors and lymphomas.
Cancer chemotherapy and pharmacology 2010;65(2):383-9.
2009: Sreenivasa R Chandana; BA Conley
Neoadjuvant chemotherapy for locally advanced squamous cancers of the head and neck: current status and future prospects.
Current opinion in oncology 2009;21(3):218-23.
2008: Kerby Shedden; Jeremy Taylor; Steven A Enkemann; Ming Tsao; Timothy J Yeatman; William L Gerald; Steven Eschrich; Igor Jurisica; Thomas J Giordano; David E Misek; Andrew C Chang; Chang-Qi Zhu; Daniel Strumpf; Samir Hanash; Frances A Shepherd; Keyue Ding; Lesley Seymour; Katsuhiko Naoki; Nathan Pennell; Barbara Weir; Roel Verhaak; Christine Ladd-Acosta; Todd Golub; Michael Gruidl; Anupama Sharma; Janos Szoke; Maureen Zakowski; Valerie W Rusch; Mark G Kris; Agnes Viale; Noriko Motoi; William D Travis; BA Conley; Venkatraman E Seshan; Matthew Meyerson; Rork Kuick; Kevin K Dobbin; Tracy Lively; James W Jacobson; David G Beer
Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study.
Nature medicine 2008;14(8):822-7.
2008: Sreenivasa R Chandana; BA Conley
Salivary gland cancers: current treatments, molecular characteristics and new therapies.
Expert review of anticancer therapy 2008;8(4):645-52.
2008: Anas Al-Janadi; Sreenivasa R Chandana; BA Conley
Histone deacetylation : an attractive target for cancer therapy?
Drugs in R&D 2008;9(6):369-83.
2007: Shivaani Kummar; Martin Gutierrez; Erin R Gardner; Erin Donovan; Kyunghwa Hwang; Eun Joo Chung; Min-Jung Lee; Kim Maynard; Mikhail Kalnitskiy; Alice Chen; Giovanni Melillo; Qin C Ryan; BA Conley; William D Figg; Jane Trepel; James Zwiebel; James Doroshow; Anthony J Murgo
Phase I trial of MS-275, a histone deacetylase inhibitor, administered weekly in refractory solid tumors and lymphoid malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(18 Pt 1):5411-7.
2007: J Philip Kuebler; H Samuel Wieand; Michael J O'Connell; Roy E Smith; Linda H Colangelo; Greg Yothers; Nicholas J Petrelli; Michael P Findlay; Thomas E Seay; James N Atkins; John L Zapas; J Wendall Goodwin; Louis Fehrenbacher; Ramesh K Ramanathan; BA Conley; Patrick J Flynn; Gamini Soori; Lauren K Colman; Edward A Levine; Keith S Lanier; Norman Wolmark
Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(16):2198-204.
2006: BA Conley; John J Wright; Shivaani Kummar
Targeting epigenetic abnormalities with histone deacetylase inhibitors.
Cancer 2006;107(4):832-40.
2006: BA Conley
Treatment of advanced head and neck cancer: what lessons have we learned?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(7):1023-5.
2006: Milin R Acharya; Alex Sparreboom; Edward A Sausville; BA Conley; James Doroshow; Jürgen Venitz; William D Figg
Interspecies differences in plasma protein binding of MS-275, a novel histone deacetylase inhibitor.
Cancer chemotherapy and pharmacology 2006;57(3):275-81.
2005: Carter Van Waes; Angela A Chang; Peter F Lebowitz; Colleen H Druzgal; Zhong Chen; Yusri A Elsayed; John B Sunwoo; Susan F Rudy; John C Morris; James B Mitchell; Kevin A Camphausen; David Gius; Julian Adams; Edward A Sausville; BA Conley
Inhibition of nuclear factor-kappaB and target genes during combined therapy with proteasome inhibitor bortezomib and reirradiation in patients with recurrent head-and-neck squamous cell carcinoma.
International journal of radiation oncology, biology, physics 2005;63(5):1400-12.
2005: Daniel J Sargent; BA Conley; Carmen Allegra; Laurence Collette
Clinical trial designs for predictive marker validation in cancer treatment trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(9):2020-7.
2005: Kevin Dobbin; David G Beer; Matthew Meyerson; Timothy J Yeatman; William L Gerald; James W Jacobson; BA Conley; Kenneth H Buetow; Mervi Heiskanen; Richard M Simon; John D Minna; Luc Girard; David E Misek; Jeremy Taylor; Samir Hanash; Katsuhiko Naoki; David Hayes; Christine Ladd-Acosta; Steven A Enkemann; Agnes Viale; Thomas J Giordano
Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarrays.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(2 Pt 1):565-72.
2004: James V Tricoli; Mason Schoenfeldt; BA Conley
Detection of prostate cancer and predicting progression: current and future diagnostic markers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(12 Pt 1):3943-53.
2004: BA Conley; Sheila E Taube
Prognostic and predictive markers in cancer.
Disease markers 2004;20(2):35-43.
2002: BA Conley; Rebecca A Enos; Bruce D Cheson
Clinical trials referral resource. Targeted therapy in squamous cell cancers of the head and neck.
Oncology (Williston Park, N.Y.) 2002;16(5):621-2, 625-6.
2001: Oscar S Breathnach; Boris Freidlin; BA Conley; Mark R Green; D H Johnson; David R Gandara; M O'Connell; F A Shepherd; Bruce E Johnson
Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(6):1734-42.
2001: BA Conley; R Cumberlin; A Sandberg; B Solomon; Carter Van Waes
NIH symposium summary: organ preservation therapies for squamous cancers of the head and neck.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(3):745-53.
2001: Rosemary Yancik; Patricia Anne Ganz; C G Varricchio; BA Conley
Perspectives on comorbidity and cancer in older patients: approaches to expand the knowledge base.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(4):1147-51.
2001: Mohan Suntharalingam; ML Haas; David A Van Echo; Robert I Haddad; M C Jacobs; S Levy; William C Gray; Robert A Ord; BA Conley
Predictors of response and survival after concurrent chemotherapy and radiation for locally advanced squamous cell carcinomas of the head and neck.
Cancer 2001;91(3):548-54.
2000: Carolyn Corlies Compton; L P Fielding; L J Burgart; BA Conley; H S Cooper; S R Hamilton; M Elizabeth H Hammond; Donald E Henson; RV Hutter; Raymond B Nagle; M L Nielsen; D J Sargent; C R Taylor; M Welton; C Willett
Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.
Archives of pathology & laboratory medicine 2000;124(7):979-94.
2000: BA Conley; Robert Gore-Langton; B D Cheson
Clinical trials, referral resource. Treatment of advanced or recurrent squamous cell carcinoma of the head and neck.
Oncology (Williston Park, N.Y.) 2000;14(4):553-4, 559, 561.
2000: Mohan Suntharalingam; ML Haas; BA Conley; Merrill J Egorin; S Levy; S Sivasailam; JOSEPH HERMAN; M C Jacobs; William C Gray; Robert A Ord; Joseph Aisner; David A Van Echo
The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck.
International journal of radiation oncology, biology, physics 2000;47(1):49-56.
2000: S H Park; William C Gray; I Hernandez; M Jacobs; Robert A Ord; M Sutharalingam; R G Smith; David A Van Echo; Suhlan Wu; BA Conley
Phase I trial of all-trans retinoic acid in patients with treated head and neck squamous carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(3):847-54.
2000: BA Conley; Joyce A O'Shaughnessy; Sheila A Prindiville; J Lawrence; Catherine Chow; E Jones; Maria J Merino; Muriel I Kaiser-Kupfer; Rafael C Caruso; MJ Podgor; Barry Goldspiel; David Venzon; David N Danforth; Suhlan Wu; MH Noone; J Goldstein; Kenneth H Cowan; Jo Anne Zujewski
Pilot trial of the safety, tolerability, and retinoid levels of N-(4-hydroxyphenyl) retinamide in combination with tamoxifen in patients at high risk for developing invasive breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(2):275-83.
1999: Gregory T Wolf; Arlene A Forastiere; K. Kian Ang; Bruce E Brockstein; BA Conley; Helmuth Goepfert; Dennis H Kraus; Jean-Louis Lefebvre; Thomas F Pajak; David G Pfister; Susan G Urba
Workshop report: organ preservation strategies in advanced head and neck cancer--current status and future directions.
Head & neck 1999;21(8):689-93.
1999: BA Conley; JK Smiley; BD Cheson
Clinical trials. NCI clinical trials in colon cancer.
Oncology (Williston Park, N.Y.) 1999;13(6):814, 817-8, 820.
1999: BA Conley; T S Ramsland; DL Sentz; Suhlan Wu; DM Rosen; M Wollman; Julie L Eiseman
Antitumor activity, distribution, and metabolism of 13-cis-retinoic acid as a single agent or in combination with tamoxifen in established human MCF-7 xenografts in mice.
Cancer chemotherapy and pharmacology 1999;43(3):183-97.
1998: BA Conley; JK Smiley; BD Cheson
Clinical trials referral resource. Clinical trials in gastric cancer.
Oncology (Williston Park, N.Y.) 1998;12(12):1751-2.
1998: BA Conley; JK Smiley; BD Cheson
Clinical trials referral resource. Clinical trials of multimodality approaches for advanced esophageal cancer.
Oncology (Williston Park, N.Y.) 1998;12(6):856-8, 861, 865.
1998: Rafael C Caruso; Jo Anne Zujewski; Fumino Iwata; MJ Podgor; BA Conley; L M Ayres; Muriel I Kaiser-Kupfer
Effects of fenretinide (4-HPR) on dark adaptation.
Archives of ophthalmology 1998;116(6):759-63.
1998: BA Conley; Merrill J Egorin; Nancy Tait; DM Rosen; Edward A Sausville; George J Dover; R J Fram; David A Van Echo
Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(3):629-34.
1998: BA Conley; Richard S. Kaplan; Arbuck Susan
National Cancer Institute Clinical Trials Program in Colorectal Cancer.
Cancer chemotherapy and pharmacology 1998;42 Suppl():S75-9.
1997: BA Conley; B D Cheson
Clinical trials referral resource. Clinical trials in head and neck cancer.
Oncology (Williston Park, N.Y.) 1997;11(10):1527-30.
1997: BA Conley; M Jacobs; Mohan Suntharalingam; D Zacharski; Robert A Ord; W Gray; Joseph Aisner
A pilot trial of paclitaxel, carboplatin, and concurrent radiotherapy for unresectable squamous cell carcinoma of the head and neck.
Seminars in oncology 1997;24(1 Suppl 2):S2-78-S2-80.
1997: Gini F Fleming; S E Waggoner; S Wu; Jacob Rotmensch; BA Conley
Re: Response of aleukemic granulocytic sarcoma to all-trans-retinoic acid plus interferon alfa-2a.
Journal of the National Cancer Institute 1997;89(2):172-3.
1997: BA Conley; Merrill J Egorin; R Sridhara; R Finley; Ramzi K Hemady; Suhlan Wu; Nancy Tait; David A Van Echo
Phase I clinical trial of all-trans-retinoic acid with correlation of its pharmacokinetics and pharmacodynamics.
Cancer chemotherapy and pharmacology 1997;39(4):291-9.
1996: BA Conley; Robert A Ord
Current status of retinoids in chemoprevention of oral squamous cell carcinoma: an overview.
Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 1996;24(6):339-45.
1995: M S Sheikh; Zhi-min Shao; X S Li; J V Ordonez; BA Conley; S Wu; Marcia I Dawson; Qi-Xia Han; Wan-Ru Chao; T Quick
N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma.
Carcinogenesis 1995;16(10):2477-86.
1995: Joseph Aisner; Chandra P Belani; C Kearns; BA Conley; D Hiponia; C Engstrom; Eleanor G Zuhowski; Merrill J Egorin
Feasibility and pharmacokinetics of paclitaxel, carboplatin, and concurrent radiotherapy for regionally advanced squamous cell carcinoma of the head and neck and for regionally advanced non-small cell lung cancer.
Seminars in oncology 1995;22(5 Suppl 12):17-21.
1995: Joseph Aisner; D Hiponia; BA Conley; M Jacobs; W Gray; Chandra P Belani
Combined modalities in the treatment of head and neck cancers.
Seminars in oncology 1995;22(3 Suppl 6):28-34.
1995: BA Conley; S O'Hara; Suhlan Wu; T J Melink; H Parnes; E Pardoe; Merrill J Egorin; David A Van Echo
Phase I trial of chloroguinoxaline sulfonamide, with correlation of its pharmacokinetics and pharmacodynamics.
Cancer chemotherapy and pharmacology 1995;37(1-2):139-49.
1994: M S Sheikh; Zhi-min Shao; X S Li; M Dawson; A M Jetten; S Wu; BA Conley; Marcel Garcia; H Rochefort; Joseph A Fontana
Retinoid-resistant estrogen receptor-negative human breast carcinoma cells transfected with retinoic acid receptor-alpha acquire sensitivity to growth inhibition by retinoids.
The Journal of biological chemistry 1994;269(34):21440-7.
1993: BA Conley; Merrill J Egorin; M Y Whitacre; D C Carter; Eleanor G Zuhowski; David A Van Echo
Phase I and pharmacokinetic trial of liposome-encapsulated doxorubicin.
Cancer chemotherapy and pharmacology 1993;33(2):107-12.
1992: Eric K Rowinsky; BA Conley; Richard J Jones; Jerry L Spivak; M Auerbach; Ross C Donehower
Hexamethylene bisacetamide in myelodysplastic syndrome: effect of five-day exposure to maximal therapeutic concentrations.
Leukemia 1992;6(6):526-34.
1992: BA Conley; Merrill J Egorin; Victoria Sinibaldi; G Sewack; C Kloc; L Roberts; Eleanor G Zuhowski; A Forrest; David A Van Echo
Approaches to optimal dosing of hexamethylene bisacetamide.
Cancer chemotherapy and pharmacology 1992;31(1):37-45.
1991: BA Conley; G F Sewack; Merrill J Egorin; B Subramanyam; John G Page; C K Grieshaber
The effect of the monoamine oxidase inhibitor isocarboxazid on the canine metabolism of the cell-differentiating agent hexamethylene bisacetamide.
Cancer chemotherapy and pharmacology 1991;28(1):33-8.
1990: BA Conley; Merrill J Egorin; Victoria Sinibaldi; David A Van Echo
Tolerance of full dose menogaril (NSC 269148) in patients with abnormal hepatic and renal function.
Investigational new drugs 1990;8(4):365-7.
1990: Mark J Ratain; Richard L Schilsky; BA Conley; Merrill J Egorin
Pharmacodynamics in cancer therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(10):1739-53.
1989: B Subramanyam; PS Callery; Merrill J Egorin; S W Snyder; BA Conley
An active, aldehydic metabolite of the cell-differentiating agent hexamethylene bisacetamide.
Drug metabolism and disposition: the biological fate of chemicals 1989;17(4):398-401.
1989: BA Conley; A Forrest; Merrill J Egorin; Eleanor G Zuhowski; Victoria Sinibaldi; David A Van Echo
Phase I trial using adaptive control dosing of hexamethylene bisacetamide (NSC 95580).
Cancer research 1989;49(12):3436-40.
1988: BA Conley; Merrill J Egorin; Eleanor G Zuhowski; Victoria Sinibaldi; D E Peterson
Salivary concentrations of hexamethylene bisacetamide (HMBA) in patients receiving 5-day continuous infusions.
Cancer chemotherapy and pharmacology 1988;22(1):65-8.
1988: BA Conley; PS Callery; Merrill J Egorin; B Subramanyam; L A Geelhaar; S S Pan
Involvement of monoamine oxidase and diamine oxidase in the metabolism of the cell differentiating agent hexamethylene bisacetamide (HMBA).
Life sciences 1988;43(9):793-800.
1987: Merrill J Egorin; BA Conley; A Forrest; Eleanor G Zuhowski; Victoria Sinibaldi; David A Van Echo
Phase I study and pharmacokinetics of menogaril (NSC 269148) in patients with hepatic dysfunction.
Cancer research 1987;47(22):6104-10.
1987: BA Conley; J Hornedo; J Abrams; Mario A Eisenberger; D Hiponia; Joseph Aisner; David A Van Echo
Phase II trial of 4'-deoxydoxorubicin in advanced non-small cell lung cancer.
Cancer treatment reports 1987;71(9):861-2.